EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis and Anti-Alzheimer’s Activity of Some Hybrid Molecule of Oxymatrine Through TGF-β

Subhendu Ghosh, Yogita Dhurandhar iD, Manoj Kumar Sahoo, Durlav Chowdhury, Ashmita Das, Deepshikha Verma, Surendra H Bodakhe, Jaya Agnihotri, Kamta P Namdeo

Current Topics in Medicinal Chemistry · 2026

DOI: 10.2174/0115680266345212250404071300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Topics in Medicinal Chemistry, 2026. Verfasst von Subhendu Ghosh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur Chhattisgarh, 495009, India. Hauptthemen laut MEDLINE: Alkaloids, Quinolizines, Alzheimer Disease, Transforming Growth Factor beta. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study aimed to investigate novel therapeutic approaches for Alzheimer's disease (AD) by targeting the Transforming Growth Factor-β (TGF-β) pathway using hybrid compounds derived from oxymatrine and amino acids.

Background

AD remains a significant challenge in neurodegenerative disorders, necessitating innovative treatments that can mitigate its devastating effects. The TGF-β pathway has been implicated in AD pathogenesis, making it a promising target for therapeutic intervention.

Objective

The objective of this study was to synthesize and evaluate the anti-AD activity of hybrid molecules combining oxymatrine with different amino acids. These compounds were designed to enhance blood-brain barrier permeability and selectively modulate TGF-β signaling.

Methods

Hybrid compounds were synthesized based on molecular docking studies. Characterization of synthesized compounds was performed using thin-layer chromatography (TLC), infrared spectroscopy (IR), and nuclear magnetic resonance (NMR) spectroscopy. Anti-AD activity was assessed using an AD rat model induced by a high-cholesterol diet, employing behavioral tests (radial arm maze and Hebb’s Williams maze) and biochemical assays to measure Aβ and TGF-β levels.

Results

All hybrid molecules exhibited significant anti-AD activity, with compound 3B demonstrating the highest efficacy at a dose of 100 mg/kg. Biochemical analyses revealed modulation of Aβ and TGF-β levels, indicating the compounds' potential therapeutic effects against AD.

Conclusion

This study unveils a new class of hybrid compounds derived from oxymatrine and amino acids that effectively target the TGF-β pathway, offering promising therapeutic potential for AD. These compounds demonstrate neuroprotective properties, suggesting they may mitigate ADrelated pathology, including tau deposition, synaptic dysfunction, and cognitive decline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlkaloidsQuinolizinesAlzheimer DiseaseTransforming Growth Factor betaDrug DesignNeuroprotective AgentsMatrinesAnimalsRatsMolecular Docking SimulationAmyloid beta-PeptidesStructure-Activity RelationshipMolecular StructureHumansDose-Response Relationship, DrugMaleMaze Learning

Stichwörter der Autor:innen

HCD.Neuronal toxicityOxymatrineTGF-βTau/GSK-3anti-Alzheimer's

Substanzen

MatrinesAlkaloidsoxymatrineQuinolizinesTransforming Growth Factor betaAmyloid beta-PeptidesNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur Chhattisgarh, 495009, India.

ORCID-Profile: Yogita Dhurandhar

Zitieren

APA

Ghosh, S., Dhurandhar, Y., Sahoo, M. K., Chowdhury, D., Das, A., Verma, D., Bodakhe, S. H., Agnihotri, J., & Namdeo, K. P. (2026). Design, Synthesis and Anti-Alzheimer’s Activity of Some Hybrid Molecule of Oxymatrine Through TGF-β. Current Topics in Medicinal Chemistry. https://doi.org/10.2174/0115680266345212250404071300

Vancouver

Ghosh S, Dhurandhar Y, Sahoo MK, Chowdhury D, Das A, Verma D, et al. Design, Synthesis and Anti-Alzheimer’s Activity of Some Hybrid Molecule of Oxymatrine Through TGF-β. Current Topics in Medicinal Chemistry. 2026. doi:10.2174/0115680266345212250404071300

BibTeX
@article{Ghosh2026,
  author = {Ghosh, Subhendu and Dhurandhar, Yogita and Sahoo, Manoj Kumar and Chowdhury, Durlav and Das, Ashmita and Verma, Deepshikha and Bodakhe, Surendra H and Agnihotri, Jaya and Namdeo, Kamta P},
  title = {Design, Synthesis and Anti-Alzheimer’s Activity of Some Hybrid Molecule of Oxymatrine Through TGF-β},
  journal = {Current Topics in Medicinal Chemistry},
  year = {2026},
  doi = {10.2174/0115680266345212250404071300}
}
Kostenlos starten →